Literature DB >> 9822282

Effects of monoclonal antibodies to adhesion molecules on eosinophilic myocarditis in Toxocara canis-infected CBA/J mice.

S Hokibara1, M Takamoto, M Isobe, K Sugane.   

Abstract

Eosinophilic myocarditis followed by fibrosis of the cardiac muscle was observed in addition to peripheral blood eosinophilia in CBA/J mice infected with Toxocara canis. The infected mice were used as an experimental model of eosinophilic endomyocarditis associated with hypereosinophilic syndrome. Effects of in vivo treatment with MoAbs to adhesion molecules on eosinophilic myocarditis were examined using this experimental model. Expressions of intercellular adhesion molecule-1 (ICAM-1) and vascular cell adhesion molecule-1 (VCAM-1) on endothelial cells of capillaries in myocardium were increased 1 and 2 weeks after infection. Infiltration of very late antigen (VLA)-4+ and/or CD11a+ cells into the cardiac muscles was also observed 1 and 2 weeks after infection. Infiltration of eosinophils into the heart was significantly suppressed by anti-CD18 MoAb and anti-VLA-4 MoAb, and focal fibrosis of the cardiac muscle was also significantly suppressed by combined administration of anti-CD18 and anti-ICAM-1 MoAbs. These results indicate that adhesion molecules may play important roles in eosinophilic myocarditis, and that blockade of interaction between adhesion molecules and their ligands may help to control it.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9822282      PMCID: PMC1905108          DOI: 10.1046/j.1365-2249.1998.00661.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  36 in total

1.  Inhibition of mixed lymphocyte response by a rat monoclonal antibody to a novel murine lymphocyte activation antigen (MALA-2).

Authors:  F Takei
Journal:  J Immunol       Date:  1985-03       Impact factor: 5.422

Review 2.  The hypereosinophilic syndrome: analysis of fourteen cases with review of the literature.

Authors:  M J Chusid; D C Dale; B C West; S M Wolff
Journal:  Medicine (Baltimore)       Date:  1975-01       Impact factor: 1.889

3.  Purification and characterization of excretory and secretory antigen of Toxocara canis larvae.

Authors:  K Sugane; T Oshima
Journal:  Immunology       Date:  1983-09       Impact factor: 7.397

4.  The cardiovascular manifestations of the hypereosinophilic syndrome. Prospective study of 26 patients, with review of the literature.

Authors:  J E Parrillo; J S Borer; W L Henry; S M Wolff; A S Fauci
Journal:  Am J Med       Date:  1979-10       Impact factor: 4.965

5.  Cytotoxic properties of the eosinophil major basic protein.

Authors:  G J Gleich; E Frigas; D A Loegering; D L Wassom; D Steinmuller
Journal:  J Immunol       Date:  1979-12       Impact factor: 5.422

6.  The in vivo cardiotoxic effect of eosinophilic cationic protein in an animal preparation.

Authors:  C Kishimoto; C J Spry; P C Tai; N Tomioka; C Kawai
Journal:  Jpn Circ J       Date:  1986-12

7.  The role of lymphokine-activated cell-associated antigen. III. Inhibition of T-cell activation by monoclonal killer-blocking antibody.

Authors:  T Nishimura; H Yagi; N Sato; S Ohta; Y Hashimoto
Journal:  Cell Immunol       Date:  1987-06       Impact factor: 4.868

8.  Toxic effects of human eosinophil products on isolated rat heart cells in vitro.

Authors:  P C Tai; D J Hayes; J B Clark; C J Spry
Journal:  Biochem J       Date:  1982-04-15       Impact factor: 3.857

9.  Eosinophilia, granuloma formation and migratory behaviour of larvae in the congenitally athymic mouse infected with Toxocara canis.

Authors:  K Sugane; T Oshima
Journal:  Parasite Immunol       Date:  1982-09       Impact factor: 2.280

10.  Deposits of eosinophil granule proteins in cardiac tissues of patients with eosinophilic endomyocardial disease.

Authors:  P C Tai; S J Ackerman; C J Spry; S Dunnette; E G Olsen; G J Gleich
Journal:  Lancet       Date:  1987-03-21       Impact factor: 79.321

View more
  2 in total

Review 1.  Concordance of preclinical and clinical pharmacology and toxicology of therapeutic monoclonal antibodies and fusion proteins: cell surface targets.

Authors:  Peter J Bugelski; Pauline L Martin
Journal:  Br J Pharmacol       Date:  2012-06       Impact factor: 8.739

2.  Eosinophil-derived IL-4 drives progression of myocarditis to inflammatory dilated cardiomyopathy.

Authors:  Nicola L Diny; G Christian Baldeviano; Monica V Talor; Jobert G Barin; SuFey Ong; Djahida Bedja; Allison G Hays; Nisha A Gilotra; Isabelle Coppens; Noel R Rose; Daniela Čiháková
Journal:  J Exp Med       Date:  2017-03-16       Impact factor: 14.307

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.